Sputnik V COVID-19 Vaccine Team Discusses EU Development Plan With EMA

A Second Russian Vaccine Has Claimed Full Effectiveness

The team behind Russia’s first COVID-19 vaccine has asked for scientific advice from EU drug regulators in view of a possible submission for marketing authorization.

Russia Sputnik Vaccine
Russia's Sputnik V vaccine has been approved in several counties • Source: Shutterstock

The European Medicines Agency has held a preliminary meeting with the developers of the Russian Sputnik V COVID-19 vaccine to discuss the product’s development program with a view to evaluating it for possible EU approval. The agency clarified that the vaccine is not under review.

The team behind Sputnik V has also requested scientific advice on the vaccine from the EMA

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography